Meritage Portfolio Management Emergent Bio Solutions Inc. Transaction History

Meritage Portfolio Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 25, 2019	SELL	$48.23 - $66.16 $4.82 Million - $6.62 Million	-100,004 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$55.63 - $73.24 $94,515 - $124,434	-1,699 Reduced 1.67%	100,004 $5.93 Million
Q3 2018 Oct 30, 2018	SELL	$52.05 - $66.51 $58,452 - $74,690	-1,123 Reduced 1.09%	101,703 $6.7 Million
Q2 2018 Jul 25, 2018	BUY	$48.33 - $55.64 $4.97 Million - $5.72 Million	102,826 New	102,826 $5.19 Million

162

33.2M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $499M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.